Free Trial

Ondine Biomedical (OBI) Competitors

Ondine Biomedical logo
C$8.50 0.00 (0.00%)
As of 05/22/2025 03:41 PM Eastern

OBI vs. VRP, ARIX, 4BB, BVXP, CIR, AVCT, HVO, TILS, VSN, and SCLP

Should you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), 4basebio (4BB), Bioventix (BVXP), Circassia Group (CIR), Avacta Group (AVCT), hVIVO (HVO), Tiziana Life Sciences (TILS), Verseon (VSN), and Scancell (SCLP). These companies are all part of the "biotechnology" industry.

Ondine Biomedical vs.

Ondine Biomedical (LON:OBI) and Verona Pharma plc (VRP.L) (LON:VRP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Verona Pharma plc (VRP.L) received 226 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 64.67% of users gave Verona Pharma plc (VRP.L) an outperform vote.

CompanyUnderperformOutperform
Ondine BiomedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes
Verona Pharma plc (VRP.L)Outperform Votes
227
64.67%
Underperform Votes
124
35.33%

20.6% of Ondine Biomedical shares are held by institutional investors. 36.7% of Ondine Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Verona Pharma plc (VRP.L) has lower revenue, but higher earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Verona Pharma plc (VRP.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ondine BiomedicalC$48.60K1,257.61-C$424.66K-C$3.32-2.56
Verona Pharma plc (VRP.L)N/AN/AN/A-£32.70N/A

In the previous week, Ondine Biomedical's average media sentiment score of 0.00 equaled Verona Pharma plc (VRP.L)'saverage media sentiment score.

Company Overall Sentiment
Ondine Biomedical Neutral
Verona Pharma plc (VRP.L) Neutral

Verona Pharma plc (VRP.L) has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. Verona Pharma plc (VRP.L)'s return on equity of 0.00% beat Ondine Biomedical's return on equity.

Company Net Margins Return on Equity Return on Assets
Ondine Biomedical-873.84% -684.01% -159.71%
Verona Pharma plc (VRP.L) N/A N/A N/A

Summary

Ondine Biomedical and Verona Pharma plc (VRP.L) tied by winning 5 of the 10 factors compared between the two stocks.

Get Ondine Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OBI vs. The Competition

MetricOndine BiomedicalBiotechnology IndustryMedical SectorLON Exchange
Market CapC$61.12MC$129.23MC$5.33BC$2.63B
Dividend YieldN/A3.74%5.21%5.05%
P/E Ratio-2.563.4326.79131.76
Price / Sales1,257.614,208.20393.69224,661.12
Price / Cash1.9913.1938.2528.03
Price / Book984.4133.136.773.79
Net Income-C$424,655.77-C$91.56MC$3.23BC$5.88B
7 Day Performance3.03%2.66%0.42%0.38%
1 Month Performance-8.11%7.34%9.06%21.42%
1 Year Performance9.11%100.71%18.55%129.81%

Ondine Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OBI
Ondine Biomedical
N/AC$8.50
flat
N/A+22.7%C$61.12MC$48,596.29-2.56N/A
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
4BB
4basebio
N/AGBX 1,150
+2.2%
GBX 1,600
+39.1%
-20.7%£147.32M£311,000.00-1,474.36101News Coverage
Gap Down
BVXP
Bioventix
N/AGBX 2,800
-2.6%
N/A-33.7%£146.62M£13.65M18.1112News Coverage
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
AVCT
Avacta Group
N/AGBX 35.18
+3.5%
N/A-30.9%£133.63M£26.29M-4.53120News Coverage
HVO
hVIVO
N/AGBX 18.25
-0.3%
N/A-35.2%£129.14M£68.74M7.53N/A
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M£-3,595,000.00-3.5911
VSN
Verseon
N/AN/AN/AN/A£112.24MN/A-5.17N/AGap Up
SCLP
Scancell
N/AGBX 9
-2.7%
N/A-2.0%£93.22MN/A-13.8051News Coverage
Insider Trade
Gap Down

Related Companies and Tools


This page (LON:OBI) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners